<?xml version="1.0" encoding="UTF-8"?>
<p>There is a lack of data on the incidence of left ventricular systolic dysfunction, acute left ventricular failure, and cardiogenic shock. One study demonstrated heart failure in 52% of deceased patients and 12% of discharged patients.
 <xref rid="clc23406-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref> Many critically ill patients may develop reversible sepsis‐related cardiomyopathy with left ventricular dilatation, impaired systolic function and recovery within 7 to 10 days.
 <xref rid="clc23406-bib-0021" ref-type="ref">
  <sup>21</sup>
 </xref> COVID‐19 infection can cause decompensation of underlying heart failure and may lead to mixed shock syndrome (combination of septic shock and cardiogenic shock). Invasive hemodynamic monitoring, if feasible, may be helpful to manage the cardiac component of shock in such cases.
 <xref rid="clc23406-bib-0026" ref-type="ref">
  <sup>26</sup>
 </xref>
</p>
